Join to View Full Profile
2000 16th StDenver, CO 80202
Phone+1 615-294-8534
Dr. Giullian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Giullian is the Chief Medical Officer at DaVita, a dialysis and holistic kidney care organization. He received his medical degree from Vanderbilt University School of Medicine and MBA from the University of Colorado at Denver. Prior to joining DaVita in 2016, Dr. Giullian practiced general and transplant nephrology and served in several hospital and national organization leadership positions.
Education & Training
Vanderbilt University Medical CenterFellowship, Nephrology, 2005 - 2008
Baylor College of MedicineResidency, Internal Medicine, 2001 - 2005
Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
CO State Medical License 2019 - 2027
WA State Medical License 2019 - 2026
OR State Medical License 2019 - 2025
PA State Medical License 2018 - 2024
TN State Medical License 2019 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 7 citationsLifesaving Care for Patients with Kidney Failure during the War in Ukraine 2022.Natalia Stepanova, Mykola Kolesnyk, Zain Mithani, Baneen Alkofair, Rebecca Lauren Shakour
Clinical Journal of the American Society of Nephrology. 2022-07-01 - 15 citationsComparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.Steven M Brunelli, Scott Sibbel, Steph Karpinski, Gilbert Marlowe, Adam G Walker
Journal of the American Society of Nephrology. 2022-04-01 - 3 citationsThe Large Kidney Care Organizations' Experience With the New Kidney Models.Jeffrey Giullian, Bryan Becker, Terry Ketchersid
Advances in Chronic Kidney Disease. 2022-01-01
Press Mentions
Dialysis Centers: Give Us a Chance at COVID VaccinationFebruary 1st, 2021- Dialysis Path Leads to Improvements in Health EquityJanuary 19th, 2021
COVID-19 Crisis Could Speed Adoption of Home DialysisApril 24th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
